Watch Demo

Iceland Antihypertensive Industry Outlook 2022 - 2026

See how Iceland Antihypertensive performed compared to key markets such as Germany, Italy and Spain.

Key Market Indicators

Icelander Antihypertensive Medicine Sales are set to reach $750,000 by 2026, growing at a rate of 2.3% year on year. Since 1994, demand for these products in Iceland has been steadily increasing at 10.5% year on year. In 2021, Iceland ranked 25th in terms of total sales, with Costa Rica one position ahead at $660,000. Italy, Spain and Australia occupied the 2nd, 3rd and 4th positions in the ranking, respectively.

Iceland Antihypertensive Market Data and Forecasts

How much will Iceland Antihypertensive Market grow to 2026?

Forecast: Renin-Angiotensin System Medicine Sales in Iceland
Forecast: Antihypertensive Medicine Sales in Iceland
Forecast: Antihypertensive Medicine Sales in Iceland
Forecast: Antihypertensive Medicine Sales in Iceland
Forecast: Antihypertensive Medicine Sales in Iceland
More in Antihypertensive Industry for 2027

Improve your Knowledge with the latest Indicators and Trends